Global Wearable Cardiac Devices Market Predicted to Register $7,733.1 Million and Grow at 26.5% CAGR by 2027 Post Covid-19 Catastrophe | Research Dive
05 sept. 2022 09h00 HE
|
Research Dive
New York, USA, Sept. 05, 2022 (GLOBE NEWSWIRE) -- According to the report published by Research Dive, the global wearable cardiac devices market is predicted to register a revenue of $7,733.1...
BioSig Strengthens Marketing and Sales Teams, Appoints National Account Executives to Scale Commercial Growth
30 août 2022 09h37 HE
|
BioSig Technologies, Inc.
Westport, CT, Aug. 30, 2022 (GLOBE NEWSWIRE) -- Company increases sales efforts and strategy, adds new National Account Executives to accelerate commercial growth Strengthens marketing team with...
BioSig Places Second PURE EP™ System For Evaluation at Cleveland Clinic a Leading Medical Center of Excellence
24 août 2022 09h17 HE
|
BioSig Technologies, Inc.
Westport, CT, Aug. 24, 2022 (GLOBE NEWSWIRE) -- Leading Medical Center of Excellence adds second PURE EP™ System for evaluation, broadening physician access to the Company’s signal processing...
BioSig’s Cardiac Signal Processing Technology To Be Featured at Kansas City Heart Rhythm Symposium 2022
17 août 2022 09h15 HE
|
BioSig Technologies, Inc.
Westport, CT, Aug. 17, 2022 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) ("BioSig" or the "Company"), a medical technology company advancing electrophysiology workflow by delivering...
BioSig Sees Positive Momentum from Sales Pipeline Growth
16 août 2022 09h47 HE
|
BioSig Technologies, Inc.
Westport, CT, Aug. 16, 2022 (GLOBE NEWSWIRE) -- Company sees increase in medical centers entering into 60-day evaluation agreements Existing customers seeing positive results from PURE EP™ System...
Defibrillator Market Size is projected to reach USD 21 Billion by 2030, growing at a CAGR of 7.18%: Straits Research
03 août 2022 13h00 HE
|
Straits Research
New York, United States, Aug. 03, 2022 (GLOBE NEWSWIRE) -- A Defibrillator administers a therapeutic shock to a patient's heart in life-threatening circumstances such ventricular fibrillation,...
BioSig Announces Physician-Initiated Research Protocol at The Kansas City Heart Rhythm Institute
21 juil. 2022 10h00 HE
|
BioSig Technologies, Inc.
Westport, CT, July 21, 2022 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”) a medical technology company advancing electrophysiology workflow by delivering...
BioSig Announces Purchase Agreement with Kansas City Heart Rhythm Institute at Overland Park Regional Medical Center
07 juil. 2022 08h30 HE
|
BioSig Technologies, Inc.
Westport, CT, July 07, 2022 (GLOBE NEWSWIRE) -- OPRMC marks our first leasing agreement under new program Company also inks national master agreement with one of the largest U.S. healthcare...
BioSig Announces Closing of Public Offering of Common Stock
29 juin 2022 17h45 HE
|
BioSig Technologies, Inc.
Westport, CT, June 29, 2022 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”) a medical technology company advancing electrophysiology workflow by delivering...
BioSig Announces Pricing of Public Offering of Common Stock
24 juin 2022 09h30 HE
|
BioSig Technologies, Inc.
Westport, CT, June 24, 2022 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”) a medical technology company advancing electrophysiology workflow by delivering...